传AT&T洽售DirecTV等电视业务少数股权
《CNBC》引述消息人士报道,AT&T(T.US)正在与包括Apollo Management在内的私募股权公司进行谈判,以出售旗下DirecTV、AT&T Now,以及收费电视U-Verse业务的少数股权。
根据拟议的交易协议,AT&T将保留业务的多数控股权,并保留包括工厂及光纤在内的基础设施的控制权,而买方将控制付费电视的发行业务。
据悉,在包括债权人下DirecTV的估值可能不超过150亿美元,远不及AT&T在2015年收购DirecTV时的670亿美元,不过消息人士称,今次交易将不包括DirecTV的拉丁美洲业务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.